News OEM
New Biomaterials for your immunoassay development & manufacturing
June 19, 2024
When developing a new immunoassay, having a deep knowledge of the biomaterial helps to optimize R&D resources.
And what is more, it helps reduce the risk in later stages of the project, where significant commitments are made and the cost of responding to unexpected events increases exponentially.
How Werfen can support you
Our experience in immunoassay development and manufacturing helps us understand the challenges you might face as an immunoassay developer & manufacturer.
In Werfen, we can support your portfolio expansion by supplying reliable biomaterials that have already been used in different immunoassay technologies.
Following our strategy to expand and diversify our biomaterials’ portfolio, we have added the following references:
AMH Antibody-Like Protein
Osteocalcin Monoclonal Antibodies
Recombinant Toxoplasma Antigen
Click here to download our updated catalogue
NEWS
Latest News
August 6, 2024
June 19, 2024
Please contact us directly via telephone or with the following form.
Tel. +34 93 860 90 00